ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.51
+0.14 (2.61%)
Dec 20, 2024, 4:00 PM EST - Market closed
ENDRA Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 18 | 13 | 29 | 25 | 13 | |
| Market Cap Growth | -55.00% | 39.49% | -55.92% | 15.68% | 100.27% | 13.06% | |
| Enterprise Value | -1 | 15 | 6 | 18 | 22 | 11 | |
| Last Close Price | 5.51 | 3710.00 | 7122.51 | 24213.02 | 26250.03 | 58800.06 | |
| PB Ratio | 0.45 | 3.17 | 1.78 | 2.70 | 3.51 | 2.64 | |
| P/TBV Ratio | 0.57 | 3.17 | 1.78 | 2.70 | 3.51 | 2.64 | |
| Debt / Equity Ratio | 0.07 | 0.10 | 0.10 | 0.07 | 0.11 | 0.15 | |
| Quick Ratio | 5.83 | 3.14 | 2.87 | 6.13 | 7.33 | 2.98 | |
| Current Ratio | 6.10 | 3.36 | 3.16 | 7.83 | 8.32 | 3.15 | |
| Return on Equity (ROE) | -149.45% | -156.42% | -146.53% | -125.11% | -196.57% | -241.73% | |
| Return on Assets (ROA) | -62.40% | -82.05% | -74.26% | -66.42% | -90.19% | -94.13% | |
| Return on Capital (ROIC) | -77.34% | -93.19% | -84.38% | -73.64% | -107.05% | -115.24% | |
| Earnings Yield | -298.09% | -56.13% | -102.57% | -38.53% | -46.53% | -105.74% | |
| FCF Yield | -273.20% | -53.47% | -100.96% | -38.31% | -42.94% | -68.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.